Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA).
Authors:
- H KobayashiHKH Kobayashi
- M SchmittMSM Schmitt
- L GoretzkiLGL Goretzki
- N ChucholowskiNCN Chucholowski
- J CalveteJCJ Calvete
- M KramerMKM Kramer
- W A GünzlerWGW A Günzler
- F JänickeFJF Jänicke
- H GraeffHGH Graeff
Open Access
- 1 March 1991
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 266 (8) , 5147-5152
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Cathepsin D and Prognosis in Breast CancerNew England Journal of Medicine, 1990
- CATHEPSIN D: AN INDEPENDENT PROGNOSTIC FACTOR FOR METASTASIS OF BREAST CANCERThe Lancet, 1989
- UROKINASE-TYPE PLASMINOGEN ACTIVATOR ANTIGEN AND EARLY RELAPSE IN BREAST CANCERThe Lancet, 1989
- Elastase released from human granulocytes stimulated with N‐formyl‐chemotactic peptide prevents activation of tumor cell prourokinase (pro‐uPA)FEBS Letters, 1989
- Degradation of laminin by human tumor cathepsin BClinical & Experimental Metastasis, 1989
- In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface-bound urokinase.Journal of Cell Biology, 1988
- Cathepsin D inactivates cysteine proteinase inhibitors cystatinsBiochemical and Biophysical Research Communications, 1988
- Intracellular transport and processing of lysosomal cathepsin BBiochemical and Biophysical Research Communications, 1987
- The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type.Journal of Cell Biology, 1986
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970